Inventor
KWON BYOUNG S
KR28 patents
⚠️ This page may combine multiple inventors who share the name “KWON BYOUNG S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EUTILEX CO LTD
20 patentsUS10174122B2Jan 8, 2019
Anti-human 4-1BB antibodies and uses thereof
EUTILEX CO LTD23 citations92
US10919972B2Feb 16, 2021
Anti-human 4-1BB antibodies and uses thereof
EUTILEX CO LTD1 citations71
US10774151B2Sep 15, 2020
Anti-human 4-1BB antibodies and uses thereof
EUTILEX CO LTD1 citations71
US10626183B2Apr 21, 2020
IFN-γ-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof
EUTILEX CO LTD2 citations71
US10233254B2Mar 19, 2019
Monoclonal antibody which specifically recognizes B cell lymphoma and use thereof
EUTILEX CO LTD4 citations70
US11013765B2May 25, 2021
Chimeric antigen receptor that binds HLA-DR and CAR-T cell
EUTILEX CO LTD2 citations68
US11072646B2Jul 27, 2021
Epitope for switching to TH1 cell and use thereof
EUTILEX CO LTD0 citations62
US11053298B2Jul 6, 2021
Epitope for switching to TH2 cell and use thereof
EUTILEX CO LTD0 citations62
US12559538B2Feb 24, 2026
PD-1 polypeptide variants
EUTILEX CO LTD0 citations61
US11859004B2Jan 2, 2024
Anti-human 4-1BB antibodies and uses thereof
EUTILEX CO LTD0 citations61
US10919976B2Feb 16, 2021
IFN-gamma-inducible regulatory T cell convertible anti-cancer (IRTCA) antibody and uses thereof
EUTILEX CO LTD1 citations61
US10801011B2Oct 13, 2020
Methods for isolating and proliferating autologous cancer antigen-specific CD8+ T cells
EUTILEX CO LTD1 citations59
US10570371B2Feb 25, 2020
Methods for isolating and proliferating autologous cancer antigen-specific CD8+T cells
EUTILEX CO LTD1 citations59
US11905334B2Feb 20, 2024
Anti-human VSIG4 antibodies and uses thereof
EUTILEX CO LTD0 citations58
US10927183B2Feb 23, 2021
Anti-human VSIG4 antibodies and uses thereof
EUTILEX CO LTD1 citations58
US12331116B2Jun 17, 2025
Bispecific epitope binding protein comprising anti-4-1BB antibody and a PD-1 protein or fragments thereof and use thereof
EUTILEX CO LTD0 citations57
US11951130B2Apr 9, 2024
Chimeric antigen receptor that binds HLA-DR and CAR-T cell
EUTILEX CO LTD0 citations57
US10851151B2Dec 1, 2020
Epitope for switching to TH17 cell and use thereof
EUTILEX CO LTD0 citations52
US12122845B2Oct 22, 2024
Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof
EUTILEX CO LTD0 citations47
US11395836B2Jul 26, 2022
Cancer antigen specific cytotoxic T cell
EUTILEX CO LTD0 citations46